The cell-free DNA (cfDNA) blood collection tube market is ripe with opportunities driven by the rise in lifestyle-related ...

A new blood test measures cell-free DNA to detect ALS early and distinguish it from other neurological disorders.

Fetuses at high risk for cystic fibrosis may be detected by screening of pregnant mothers using reflex to cell-free DNA analysis.

Elegen’s Gen II DNA Synthesizer Platform—built for the AI era of genetic medicine—delivers long, complex DNA at unmatched speed, quality, and scale.

The company aims to broadly offer DNA from the fully-automated, miniaturized, high-throughput, clinical-ready DNA production platform later next year Elegen, a global leader in next-generation cell-fr ...

They observe how the mobile DNA LINE-1 copies its sequence in human cells, revealing the precise mechanism of the ORF2p gene.

A label-free nanopore platform uses programmable DNA circuits to build versatile molecular logic gates, forming a universal basis for scalable DNA computing and advanced biosensing applications.

The move aims to regulate cell and gene therapies, and xenografts or animal-to-human transplants. Such therapies are ...

A major US study reveals that marijuana use leaves measurable chemical traces in DNA, altering genes related to mental health ...

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the University of Queensland developed a blood test that can spot signs of the ...